Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Characteristics and Risk of Disease Recurrence in Hormone Receptor-positive, HER2-negative Early Breast Cancer: a Multi-center Retrospective Cohort Study in Korea

NCT07309887 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT07309887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07309887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Characteristics and Risk of Disease Recurrence in Hormone Receptor-positive, HER2-negative Early Breast Cancer: a Multi-center Retrospective Cohort Study in Korea
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Not yet recruiting
Start date
December 17, 2025
Completion date
December 31, 2026
Enrollment
100,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early breast cancer